Advertisement

Cisplatin

Definition

Cisplatin, also known by the brand name Platinol-AQ, Cis-platinum, CDDP, or DDP, is a chemotherapy medicine used to treat certain types of cancer by destroying cancerous cells.

Purpose

Cisplatin is approved by the Food and Drug Administration (FDA) to treat metastatic testicular cancer and metastatic ovarian cancer. It is also approved for late-stage bladder cancer and has been used to treat other types of cancer including head and neck cancer, esophageal cancer, stomach cancer, lung cancer, skin cancer, prostate cancer, lymphoma and others (breast, neuroblastoma, sarcoma, bladder, cervical, myeloma, mesothelioma, osteosarcoma).

Description

Cisplatin is a member of the group of chemotherapy drugs known as heavy metal alkylating-like agents. These drugs interfere with the genetic material (DNA) inside the cancer cells and prevent them from further dividing and growing more cancer cells.

Cisplatin has been used to treat cancer for more than 30 years. It can be used alone or in combination with other chemotherapies, including bleomycin-etoposide, ifosfamide, gemcitabine, paclitaxel, fluorouracil-leucovorin, vinorelbine, methotrexate-vinblastine-doxorubicin. Cisplatin may also be given with radiation therapy.

Recommended dosage

A cisplatin dose can be determined using a mathematical calculation that measures body surface area (BSA), which depends on a person's overall size. Body surface area is measured in the units known as square meter (m2). The body surface area is calculated and then multiplied by the drug dosage in milligrams per m2 (mg/m2), which gives the proper dosage.

Cisplatin is a clear, colorless solution administered by an infusion into a vein. Infusions can be given once every three to four weeks over a 30 minutes up to two hours. It can also be given continuously over 24 hours a day for several days in a row. One cycle of cisplatin should not be given more frequently than once every three to four weeks. Dosages depend on the cancer being treated.

To treat metastatic testicular cancer

Dosages are 20 mg/m2 per day administered into a vein every day for five days in a row. This regimen is used in combination with other chemotherapy drugs, mainly bleomycin and etoposide or vinblastine.

To treat metastatic ovarian cancer

Dosages are 50 mg/m2 to 100 mg/m2 administered into a vein once every four weeks. This regimen can be combined with the chemotherapy drug cyclophosphamide or doxorubicin.

To treat advanced bladder cancer

Cisplatin doses range from 50 mg/m2 to 70 mg/m2 administered into a vein once every 3 to 4 weeks. Cisplatin is usually given alone for bladder cancer.

Before receiving cisplatin large volumes of intravenous fluids are given to keep the kidneys flushed with water. If patients have severe kidney problems the physician will either not use cisplatin or decrease the dose being used.

Normal metal ions found in the body, called electrolytes, can be lost due to administration of cisplatin. These may be added to these intravenous fluids for replacement.


Advertisement
Copyright © 2005 - 2012 Healthline Networks, Inc. All rights reserved.
Healthline is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations. more details